ELECTROMED INC (ELMD)
Health Care · Medical devices for respiratory care · Nyse Mkt Llc
Electromed manufactures SmartVest airway clearance devices for patients with chronic respiratory conditions.
What ELECTROMED INC does
Electromed, Inc. designs, manufactures, and markets the SmartVest Airway Clearance System, a therapeutic device that uses high-frequency chest-wall oscillation (HFCWO) technology to help patients with chronic respiratory conditions clear secretions from their airways. The company serves patients with cystic fibrosis, chronic obstructive pulmonary disease (COPD), and other conditions requiring airway management. Revenue is generated through device sales, accessories, and related respiratory care products distributed through healthcare providers and patient channels.
Themes: ["respiratory care / airway clearance"]
Fundamentals
- Price$45.82 as of 2026-07-09 close
- Market cap$364M as of 2026-07-10
- 1-year return+119.5% as of 2026-07-09 close
- P/E36.01 as of 2026-07-10
- Net margin+14.1% as of 2026-07-10
- Gross margin+78.4% as of 2026-07-10
- ROE+22.1% as of 2026-07-10
- Debt / equity0.00 as of 2026-07-10
- Revenue growth (YoY)+16.8% as of 2026-07-10
- Revenue CAGR (3y)+15.4% SEC XBRL
- Beta0.51 as of 2026-07-10
Key risks (from latest filing)
["Dependence on reimbursement from insurance providers and government payers (Medicare/Medicaid) for device sales and patient access"]
Competitors & peers
- Hill-Rom Holdings (HILL)
Fundamentals: Finnhub, as of 2026-07-10. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-09.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date.